"Passive income is the cash flow that arrives whether you are working, sleeping, or watching the market churn. For investors who have spent decades building a paycheck, the appeal of a portfolio that pays you on a fixed schedule is less about getting rich and more about getting reliable."
"Healthcare and consumer staples have long anchored income portfolios because their cash flows are largely insensitive to recession risk. The trade-off with a blue-chip name is yield: you give up the double-digit headline rate of a mortgage REIT or a BDC in exchange for a check that has not been cut, suspended, or skipped in living memory."
"Johnson & Johnson is a diversified global healthcare company that operates two reporting segments after the Kenvue spin: Innovative Medicine and MedTech. Six priority franchises drove $96.4 billion in trailing-twelve-month revenue and an operating margin of 27.4%."
Passive income, particularly from dividends, offers consistent cash flow regardless of work status. Investors favor healthcare and consumer staples for their recession-resistant cash flows. Johnson & Johnson, a Dividend King, exemplifies this with a yield of 2.26% and potential annual passive income of $119.54 from a $5,000 investment. The company, with a diverse portfolio in pharmaceuticals and medical devices, reported a 9.9% revenue increase in Q1 2026, showcasing its financial resilience and commitment to stable dividends.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]